GB00BDGKMY29
GB00BDGKMY29
BIOPHARMA CREDIT PLC ORD USD0.0
Loading chart...
Solid Quality Asset with Moderate Fluctuation
Healthy balance: Exemplary business financials (Health Score: 90/100) paired with moderate price swings for a single equity (±13.0% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta
Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.18x
DefensiveVolatility (5Y p.a.)
13.0% p.a.
5-Year HorizonMax Drawdown (5Y)
-22.7%
5-Year HorizonSharpe Ratio
-0.21
Return / RiskElevated Risk / Growth: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +7.3% |
| 3 Years | 13.7% | -14.7% | 0.16 | +4.7% |
| 5 Years | 13.0% | -22.7% | -0.21 | -0.2% |
| 10 Years | 11.9% | -28.9% | -0.27 | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Strong Long-Term Stability: The stock exhibits consistently low volatility across 5 and 10 years (<16% p.a.).